Marci Clark
Overview
Explore the profile of Marci Clark including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blauvelt A, Reckleff J, Zhao Y, Clark M, Kosa K, Harris N, et al.
Br J Dermatol
. 2024 Oct;
192(2):247-260.
PMID: 39365666
Background: Pruritus, skin pain and sleep disturbance place a significant burden on individuals with moderate-to-severe atopic dermatitis (AD) and negatively affect their quality of life. Fit-for-purpose patient-reported outcome measures (PROMs)...
2.
Williams V, Romano C, Clark M, Korver D, Williams N, Goss D, et al.
J Patient Rep Outcomes
. 2023 Oct;
7(1):105.
PMID: 37902847
Background: Patient-reported outcome measures that facilitate self-report by children are needed to reduce the bias of proxy report. We previously developed an electronic Pediatric Asthma Symptom Diary (ePASD) to assess...
3.
Paller A, Siegfried E, Marron S, Clark M, DiBenedetti D, Nelson L, et al.
J Am Acad Dermatol
. 2023 Oct;
90(2):382-385.
PMID: 37778662
No abstract available.
4.
Khan A, Kosa K, de Prado Gomez L, Whalley D, Kamat S, Clark M
Patient Relat Outcome Meas
. 2023 Mar;
14:57-71.
PMID: 36992797
Purpose: Sleep disturbance is common in patients with asthma and can lead to subsequent impacts on health-related quality of life (HRQOL). Fit-for-purpose patient-reported outcome measures (PROMs) assessing asthma-related sleep disturbance...
5.
Gnanasakthy A, Norcross L, Clark M, Fitzgerald K
JCO Oncol Pract
. 2023 Feb;
19(5):e745-e762.
PMID: 36854073
Purpose: The purpose of this project was to gain insight into the role of patient-reported outcome (PRO) data in US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC)...
6.
Clark M, Romano C, Olayinka-Amao O, Whalley D, Crawford R, Pathak P, et al.
J Patient Rep Outcomes
. 2022 Mar;
6(1):25.
PMID: 35306621
Background: Childhood asthma is an important unmet need. To date, patient-reported outcome measures (PROMs) for children with asthma have used a combination of caregiver or proxy-reported and self-reported measures. No...
7.
Harrington M, Hareendran A, Skalicky A, Wilson H, Clark M, Mikl J
J Patient Rep Outcomes
. 2019 Jul;
3(1):44.
PMID: 31338630
Background: Capturing the impact of caring for patients with debilitating rare disease is important for understanding disease burden. We aimed to develop and validate an instrument to measure the impact...
8.
Nosebleeds in hereditary hemorrhagic telangiectasia: Development of a patient-completed daily eDiary
Clark M, Berry P, Martin S, Harris N, Sprecher D, Olitsky S, et al.
Laryngoscope Investig Otolaryngol
. 2019 Jan;
3(6):439-445.
PMID: 30599027
Objective: A prospective, qualitative study was conducted to develop a patient-reported outcome measure (PROM) for daily administration via electronic diary (eDiary) to assess the severity of nosebleeds in patients with...
9.
Gnanasakthy A, DeMuro C, Clark M, Mordin M, Thomas S
Ther Innov Regul Sci
. 2018 Sep;
47(5):613-618.
PMID: 30235577
This work aimed to provide an understanding of the current use and regulatory acceptability of patient-reported outcome (PRO) measures in labeling claims for central nervous system (CNS) agents. A subset...
10.
Copley-Merriman C, Zelt S, Clark M, Gnanasakthy A
Patient
. 2016 Sep;
10(2):203-213.
PMID: 27637487
Although some symptoms of dermatologic diseases, such as pruritus and pain, can be subjectively assessed only by patients, the most commonly used endpoints in dermatology drug research traditionally have been...